Yahoo Web Search

Search results

1. • 

     Wall Street Analysts See a 75% Upside in Aerie (AERI): Can the Stock Really Move This High?

     Zacks via Yahoo Finance· 2 years ago

     The consensus price target hints at a 75.1% upside potential for Aerie (AERI). While empirical...

2. • 

     The Zacks Analyst Blog Highlights SilverBow Resources, Amalgamated Financial, PHX Minerals,...

     Zacks via Yahoo Finance· 2 years ago

     For Immediate Release Chicago, IL – October 24, 2022 – Zacks.com announces the list of stocks...

3. • 

     Aerie (AERI) to be Acquired by Alcon for $770M, Shares Up

     Zacks via Yahoo Finance· 2 years ago

     Aerie Pharmaceuticals, Inc. AERI recently announced that it has entered into an agreement with Alcon...

4. • 

     After Golden Cross, Aerie Pharmaceuticals (AERI)'s Technical Outlook is Bright

     Zacks via Yahoo Finance· 2 years ago

     From a technical perspective, Aerie Pharmaceuticals, Inc. (AERI) is looking like an interesting...

5. • 

     Aerie (AERI) Q2 Loss Narrower Than Expected, Sales Beat

     Zacks via Yahoo Finance· 2 years ago

     Aerie Pharmaceuticals AERI reported adjusted loss per share of 32 cents in second-quarter 2022,...

6. • 

     Aerie (AERI) Rallies 205.6% in the Past Three Months: Here's Why

     Zacks via Yahoo Finance· 2 years ago

     Aerie (AERI) shares have skyrocketed in the past three months after the company announced its...

7. • 

     Aerie Pharmaceuticals (AERI) Reports Q3 Loss, Tops Revenue Estimates

     Zacks via Yahoo Finance· 2 years ago

     Aerie (AERI) delivered earnings and revenue surprises of 35.71% and 2.91%, respectively, for the...

8. • 

     Alcon May Struggle To Meet 2023 Margin Targets With This Latest Acquisition, Says This Analyst

     Benzinga via Yahoo Finance· 2 years ago

     Earlier today, Alcon AG (NYSE: ALC) agreed to acquire Aerie Pharmaceuticals Inc (NASDAQ: AERI) for...

9. • 

     Catalyst Pharmaceuticals (CPRX) Q2 Earnings Top, Revenues Up

     Zacks via Yahoo Finance· 2 years ago

     Catalyst Pharmaceuticals, Inc. CPRX reported earnings of 20 cents per share in the second quarter of...

10. • 

      Catalyst Pharmaceuticals (CPRX) Rallies 80.69% YTD: Here's Why

      Zacks via Yahoo Finance· 2 years ago

      Catalyst Pharmaceuticals CPRX stock has skyrocketed 80.6% in the year-to-date period against the...